|
|
Volumn 4, Issue 4, 2013, Pages 496-497
|
|
New activities for the anti-tumor agent trabectedin: Taking two birds with one stone
a
a
b
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA;
DOXORUBICIN;
FUSED IN SARCOMA PROTEIN;
GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153;
INTERLEUKIN 6;
INTERLEUKIN 8;
MONOCYTE CHEMOTACTIC PROTEIN 1;
TRABECTEDIN;
TRANSCRIPTION FACTOR;
VASCULOTROPIN;
ADIPOCYTE;
ADJUVANT THERAPY;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
CANCER CELL;
CARCINOGENESIS;
CELL DIFFERENTIATION;
CELL PROLIFERATION;
CHOP GENE;
CHROMOSOME 12Q;
CHROMOSOME TRANSLOCATION 12;
CYTOKINE PRODUCTION;
DISEASE MODEL;
DNA BINDING;
DRUG TARGETING;
EDITORIAL;
FUS GENE;
HUMAN;
INHIBITION KINETICS;
LYMPHOCYTE;
MACROPHAGE;
MONOCYTE;
MYXOSARCOMA;
NEUTROPHIL;
NONHUMAN;
ONCOGENE;
OVARY CANCER;
OVERALL SURVIVAL;
PROTEIN EXPRESSION;
SOFT TISSUE SARCOMA;
TUMOR MICROENVIRONMENT;
TUMOR VASCULARIZATION;
TUMOR VOLUME;
TUMOR XENOGRAFT;
UROCHORDATA;
|
|
EID: 84879179814
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.968 Document Type: Editorial |
|
Times cited : (9)
|
|
References (8)
|
